Effects of Baclofen on Insular Gain Anticipation in Alcohol-dependent Patients - a Randomized, Placebo-controlled, Pharmaco-fMRI Pilot Trial

Overview

Journal Psychopharmacology (Berl)

Specialty Pharmacology

Date 2022 Dec 20

PMID 36538099

Authors

Patricia Pelz

Alexander Genauck

Robert C Lorenz

Torsten Wustenberg

Carolin Wackerhagen

Katrin Charlet

Tobias Gleich

Olga Geisel

Andreas Heinz

Christian A Muller

Anne Beck

Affiliations

Soon will be listed here.

Abstract

Rationale: One hallmark of addiction is an altered neuronal reward processing. In healthy individuals (HC), reduced activity in fronto-striatal regions including the insula has been observed when a reward anticipation task was performed repeatedly. This effect could indicate a desensitization of the neural reward system due to repetition. Here, we investigated this hypothesis in a cohort of patients with alcohol use disorder (AUD), who have been treated with baclofen or a placebo. The efficacy of baclofen in AUD patients has been shown to have positive clinical effects, possibly via indirectly affecting structures within the neuronal reward system.

Objectives: Twenty-eight recently detoxified patients (13 receiving baclofen (BAC), 15 receiving placebo (PLA)) were investigated within a longitudinal, double-blind, and randomized pharmaco-fMRI design with an individually adjusted daily dosage of 30-270 mg.

Methods: Brain responses were captured by functional magnetic resonance imaging (fMRI) during reward anticipation while participating in a slot machine paradigm before (t1) and after 2 weeks of individual high-dose medication (t2).

Results: Abstinence rates were significantly higher in the BAC compared to the PLA group during the 12-week high-dose medication phase. At t1, all patients showed significant bilateral striatal activation. At t2, the BAC group showed a significant decrease in insular activation compared to the PLA group.

Conclusions: By affecting insular information processing, baclofen might enable a more flexible neuronal adaptation during recurrent reward anticipation, which could resemble a desensitization as previously observed in HC. This result strengthens the modulation of the reward system as a potential mechanism of action of baclofen.

Trial Registration: Identifier of the main trial (the BACLAD study) at clinical.gov: NCT0126665.

References

Garbutt J, Kampov-Polevoy A, Pedersen C, Stansbury M, Jordan R, Willing L . Efficacy and tolerability of baclofen in a U.S. community population with alcohol use disorder: a dose-response, randomized, controlled trial. Neuropsychopharmacology. 2021; 46(13):2250-2256. PMC: 8580979. DOI: 10.1038/s41386-021-01055-w. View

Tsakiris M, Hesse M, Boy C, Haggard P, Fink G . Neural signatures of body ownership: a sensory network for bodily self-consciousness. Cereb Cortex. 2006; 17(10):2235-44. DOI: 10.1093/cercor/bhl131. View

Dreher J, Meyer-Lindenberg A, Kohn P, Berman K . Age-related changes in midbrain dopaminergic regulation of the human reward system. Proc Natl Acad Sci U S A. 2008; 105(39):15106-11. PMC: 2567500. DOI: 10.1073/pnas.0802127105. View

Naqvi N, Bechara A . The insula and drug addiction: an interoceptive view of pleasure, urges, and decision-making. Brain Struct Funct. 2010; 214(5-6):435-50. PMC: 3698865. DOI: 10.1007/s00429-010-0268-7. View

Goldstein R, Volkow N . Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications. Nat Rev Neurosci. 2011; 12(11):652-69. PMC: 3462342. DOI: 10.1038/nrn3119. View

Heatherton T, Kozlowski L, Frecker R, Fagerstrom K . The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict. 1991; 86(9):1119-27. DOI: 10.1111/j.1360-0443.1991.tb01879.x. View

Fadda P, Scherma M, Fresu A, Collu M, Fratta W . Baclofen antagonizes nicotine-, cocaine-, and morphine-induced dopamine release in the nucleus accumbens of rat. Synapse. 2003; 50(1):1-6. DOI: 10.1002/syn.10238. View

Craig A . How do you feel--now? The anterior insula and human awareness. Nat Rev Neurosci. 2008; 10(1):59-70. DOI: 10.1038/nrn2555. View

Lorenz R, Gleich T, Kuhn S, Pohland L, Pelz P, Wustenberg T . Subjective illusion of control modulates striatal reward anticipation in adolescence. Neuroimage. 2015; 117:250-7. DOI: 10.1016/j.neuroimage.2015.05.024. View

10.

Young K, Franklin T, Roberts D, Jagannathan K, Suh J, Wetherill R . Nipping cue reactivity in the bud: baclofen prevents limbic activation elicited by subliminal drug cues. J Neurosci. 2014; 34(14):5038-43. PMC: 3972727. DOI: 10.1523/JNEUROSCI.4977-13.2014. View

11.

Di Chiara G . Alcohol and dopamine. Alcohol Health Res World. 1997; 21(2):108-14. PMC: 6826820. View

12.

Wrase J, Schlagenhauf F, Kienast T, Wustenberg T, Bermpohl F, Kahnt T . Dysfunction of reward processing correlates with alcohol craving in detoxified alcoholics. Neuroimage. 2007; 35(2):787-94. DOI: 10.1016/j.neuroimage.2006.11.043. View

13.

Beck A, Ward C, Mendelson M, Mock J, ERBAUGH J . An inventory for measuring depression. Arch Gen Psychiatry. 1961; 4:561-71. DOI: 10.1001/archpsyc.1961.01710120031004. View

14.

di Volo M, Morozova E, Lapish C, Kuznetsov A, Gutkin B . Dynamical ventral tegmental area circuit mechanisms of alcohol-dependent dopamine release. Eur J Neurosci. 2018; 50(3):2282-2296. DOI: 10.1111/ejn.14147. View

15.

de Boer M, Waterlander W, Kuijper L, Steenhuis I, Twisk J . Testing for baseline differences in randomized controlled trials: an unhealthy research behavior that is hard to eradicate. Int J Behav Nutr Phys Act. 2015; 12:4. PMC: 4310023. DOI: 10.1186/s12966-015-0162-z. View

16.

Haber S, Knutson B . The reward circuit: linking primate anatomy and human imaging. Neuropsychopharmacology. 2009; 35(1):4-26. PMC: 3055449. DOI: 10.1038/npp.2009.129. View

17.

Shen W . Anticraving therapy for alcohol use disorder: A clinical review. Neuropsychopharmacol Rep. 2018; 38(3):105-116. PMC: 7292332. DOI: 10.1002/npr2.12028. View

18.

Singer T, Critchley H, Preuschoff K . A common role of insula in feelings, empathy and uncertainty. Trends Cogn Sci. 2009; 13(8):334-40. DOI: 10.1016/j.tics.2009.05.001. View

19.

Adinoff B . Neurobiologic processes in drug reward and addiction. Harv Rev Psychiatry. 2005; 12(6):305-20. PMC: 1920543. DOI: 10.1080/10673220490910844. View

20.

Richards J, Plate R, Ernst M . A systematic review of fMRI reward paradigms used in studies of adolescents vs. adults: the impact of task design and implications for understanding neurodevelopment. Neurosci Biobehav Rev. 2013; 37(5):976-91. PMC: 3809756. DOI: 10.1016/j.neubiorev.2013.03.004. View